List of insiders holdings for G1 Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | ESHELMAN FREDRIC N Director |
2024-02-21 16:30:39 | 4,766,074 0 |
4,766,074 | Form 13D |
| 2 | Eshelman Ventures LLC 10% Owner |
2017-05-24 20:29:42 | 3,439,151 0 |
3,439,151 | Form 4 |
| 3 | MedImmune Ventures Inc. 10% Owner |
2017-12-18 17:48:05 | 2,950,630 0 |
2,950,630 | Form 4 |
| 4 | RA CAPITAL MANAGEMENT LLC RA Capital Healthcare Fund LP Kolchinsky Peter Fmr 10% Owner See Footnote (2) |
2017-05-24 16:34:27 | 0 2,684,244 |
2,684,244 | Form 4 |
| 5 | Thorp Clay Hatteras Venture Advisors IV SBIC LLC Hatteras Venture Partners IV SBIC LP INGRAM ROBERT ALEXANDER Crumpler John LEE KENNETH B JR Reed Douglas MD 10% Owner |
2021-02-12 16:16:05 | 1,756,462 0 |
1,756,462 | Form 13G |
| 6 | Velleca Mark A. Director |
2023-08-10 16:11:04 | 358,286 0 |
358,286 | Form 4 |
| 7 | MOSSINGHOFF GREGORY J Chief Business Officer |
2017-05-16 21:18:34 | 320,565 0 |
320,565 | Form 3 |
| 8 | Strum Jay Chief Scientific Officer |
2019-01-02 17:46:25 | 144,237 0 |
144,237 | Form 4 |
| 9 | Moses Jennifer K. CFO |
2023-01-05 20:26:25 | 102,420 0 |
102,420 | Form 4 |
| 10 | SHAFFER CHRISTY L Director |
2017-12-04 17:06:30 | 0 101,503 |
101,503 | Form 4 |
| 11 | Hanson James S. General Counsel |
2023-01-05 20:25:32 | 76,787 0 |
76,787 | Form 4 |
| 12 | Gupta Soma Chief Commercial Officer |
2021-01-05 18:22:44 | 69,000 0 |
69,000 | Form 4 |
| 13 | PHILLIPS BARCLAY A SVP & Chief Financial Officer |
2019-01-02 17:29:23 | 60,000 0 |
60,000 | Form 4 |
| 14 | Deese Willie A Director |
2022-06-24 16:51:19 | 44,389 0 |
44,389 | Form 4 |
| 15 | DEMAREE JOHN Chief Commercial Officer |
2020-02-07 16:15:07 | 30,000 0 |
30,000 | Form 4 |
| 16 | RUDNICK SETH Director |
2021-06-30 16:05:05 | 16,248 5,266 |
21,514 | Form 4 |
| 17 | WITTY ANDREW Director |
2019-06-14 16:30:47 | 20,000 0 |
20,000 | Form 4 |
| 18 | Secor Alicia Director |
2024-09-18 16:15:19 | 0 0 |
0 | Form 4 |
| 19 | Thomas Monica R. Chief Legal & People Officer |
2024-09-18 16:15:18 | 0 0 |
0 | Form 4 |
| 20 | Flowers Cynthia Louise Director |
2024-09-18 16:15:17 | 0 0 |
0 | Form 4 |
| 21 | Nicholson Garry A Director |
2024-09-18 16:15:15 | 0 0 |
0 | Form 4 |
| 22 | Lee Jacks Director |
2024-09-18 16:15:15 | 0 0 |
0 | Form 4 |
| 23 | Bailey John E. (Jack) Jr. President and CEO |
2024-09-18 16:15:13 | 0 0 |
0 | Form 4 |
| 24 | Umstead John W. V Chief Financial Officer |
2024-09-18 16:15:13 | 0 0 |
0 | Form 4 |
| 25 | Malik Rajesh Chief Medical Officer |
2024-09-18 16:15:12 | 0 0 |
0 | Form 4 |
| 26 | Avagliano Mark Chief Business Officer |
2024-09-18 16:15:11 | 0 0 |
0 | Form 4 |
| 27 | Sharpless Norman Director |
2024-09-18 16:15:11 | 0 0 |
0 | Form 4 |
| 28 | MURDOCK TERRY L Chief Operating Officer |
2024-09-18 16:15:09 | 0 0 |
0 | Form 4 |
| 29 | Perry Andrew Chief Commercial Officer |
2024-09-18 16:15:05 | 0 0 |
0 | Form 4 |
| 30 | MUIR GLENN P Director |
2024-09-18 16:15:04 | 0 0 |
0 | Form 4 |
| 31 | Sullivan Timothy Eugene Director |
2017-05-19 18:59:03 | 0 0 |
0 | Form 3 |
| 32 | Rivers Tyrell Director |
2017-05-16 21:23:07 | 0 0 |
0 | Form 3 |